AP NEWS

Global $20.1 Billion Cancer Diagnostics Market by 2023: Analysis and Opportunities - ResearchAndMarkets.com

December 20, 2018

DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Global Cancer Diagnostics Market - Forecasts From 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering.

The global cancer diagnostics market is projected to grow at a CAGR of 14.22%, increasing from US$9.050 billion in 2017 to US$20.099 billion in 2023.

Cancer diagnostics market is expected to show a significant growth during the given forecast period. The rise in the market may be attributed to the rising prevalence of the disease coupled with the rising awareness among the people regarding the disease.

Initiatives undertaken by governments and global health organizations to spread awareness about cancer will also boost the market during the given forecast period. However, high cost of diagnostic imaging systems along with the high capital investments might restrain the market for cancer diagnostics during the given forecast period.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Key Findings of the Study

4. Market Dynamics

5. Global Cancer Diagnostics Market Forecast by Diagnostic Procedures

5.1. Laboratory Tests

5.2. Imaging Procedures

5.3. Biopsy

6. Global Cancer Diagnostics Market Forecast by Application

6.1. Lung Cancer

6.2. Breast Cancer

6.3. Colorectal Cancer

6.4. Skin Cancer

6.5. Stomach Cancer

6.6. Other Cancers

7. Global Cancer Diagnostics Market Forecast by End-Users

7.1. Hospitals and Clinics

7.2. Diagnostic Centres

8. Global Cancer Diagnostics Market Forecast by Geography (US$ billion)

8.1. North America

8.2. South America

8.3. Europe

8.4. Middle East and Africa

8.5. Asia Pacific

9. Competitive Intelligence

9.1. Market Share Analysis

9.2. Strategies of Key Players

9.3. Recent Investments and Deals

10. Company Profiles

10.1. bioMerieux Inc.

10.2. F. Hoffmann-La Roche Ltd.

10.3. Sienna Cancer Diagnostics

10.4. Insight Genetics

10.5. MetaCell

10.6. Cancer Genetics Inc.

10.7. Breath Diagnostics Inc.

10.8. Arquer Diagnostics Ltd.

10.9. Metabiomics

10.10. Castle Biosciences Inc.

For more information about this report visit https://www.researchandmarkets.com/research/gmgltw/global_20_1?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005905/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/19/2018 07:41 PM/DISC: 12/19/2018 07:42 PM

http://www.businesswire.com/news/home/20181219005905/en

AP RADIO
Update hourly